Diamond Drugs, Inc. 401(K) Plan — Form 5500 plan (Diamond Drugs, Inc.)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Diamond Drugs, Inc. 401(K) Plan is a benefit plan reported by Diamond Drugs, Inc. under EIN 25-1378278 and plan number 001. The latest loaded filing year is 2023. The filing reports 873 participants and $40,590,722 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Diamond Drugs, Inc.
EIN
25-1378278
Plan number
001
Plan type
2
Location
Indiana, PA
Latest filing year
2023
Participants
873
End-of-year plan assets
$40,590,722

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
2023873H, C20241015131240NAL0014695347001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$40,590,722
Total liabilities (EOY)
$108,279
Net assets (EOY)
$40,482,443
Net assets (BOY)
$34,313,941

Income & contributions

Employer contributions
$630,468
Participant contributions
$2,730,869
Total contributions
$3,383,167
Total income / additions
$8,324,651

Expenses & distributions

Benefits paid
$2,043,520
Administrative expenses
$4,350
Total expenses
$2,156,149
Net increase / (decrease)
$6,168,502

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Lincoln RetirementCUSTODIAN$39,303not reported in the loaded dataset2023
Anchor 3(16) Fiduciary Services LLCPLAN ADMINISTRATOR$10,900not reported in the loaded dataset2023
M2b Retirement Consulting, LLCTPA$7,370not reported in the loaded dataset2023

Related Form 5500 pages